[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fEk1aQJtgVA3pSOMHoQkbil5pdQYKkwcg44UjUlQFs1M":8,"$fX7g1ywpitxUSaDN9n1ywIgPGk8NdEI31G4pcqp1FPWc":55,"$fe8iXm8_TKmx2OpG7W-LRhYV4kqI1GD1VPm241sUnQ3E":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},65171,867252,[],"https://ystcdn.venuertc.com/medical/ystApp/3PMFog9SJLbtP3VML2xGXUy2tMSMprgU.png","曾珊珊","潍坊市益都中心医院","血液内科","住院医师",447,0,"急性B细胞淋巴母白血病二期：安全用药实用指南","","https://ystcdn.venuertc.com/venue/AI/50441a4a-b505-4ddf-a670-7d69c7f7ea77.jpg","\u003Cdiv class=\"leukemia-guide-material\">\n  \u003Ch1 id=\"material_title\" class=\"leukemia-guide-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    急性B细胞淋巴母白血病二期：安全用药实用指南\n  \u003C/h1>\n  \u003Cdiv class=\"leukemia-guide-intro leukemia-guide-bg-section\">\n    说起来，急性B细胞淋巴母细胞白血病（二期）治疗过程所用的药物种类广泛，涉及化疗药、靶向药、血液制品和辅助用药等。每种药品的剂型、服用方法、不良反应和禁忌都各有讲究。如何才能用对药、用好药？这篇指南将从7个关键细节入手，细讲急性B细胞淋巴母白血病二期常用药品的用法和注意事项，让患者和家属都能放心应对治疗中遇到的真实问题。        \n  \u003C/div>\n\n  \u003C!-- 01 服用时间和方法 -->\n  \u003Ch2 class=\"leukemia-guide-subtitle leukemia-guide-bg1\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 正确的服用时间和方法 ⏰\u003C/h2>\n  \u003Cdiv class=\"leukemia-guide-section\">\n    不同药品的服用时间有明确规定，部分化疗药物和靶向药有特定的服药时间要求，有些需严格按照医生的时间表执行。\u003Cbr>\n    \u003Cstrong>举例：\u003C/strong> 比如培哚普利口服化疗药，通常建议饭前1小时或饭后2小时服用，以保证药效吸收最大化。\u003Cbr>\n    \u003Cstrong>正确做法：\u003C/strong>\n    \u003Cul class=\"leukemia-guide-list\">\n      \u003Cli>对于口服药，严格遵医嘱，定时服用，不随意提前或推迟。\u003C/li>\n      \u003Cli>静脉用药需在有经验的医护人员监护下完成，自己勿私自调整滴速或时间。\u003C/li>\n      \u003Cli>输注血液制品或特定支持性药物时，应按照规定间隔与治疗药物搭配。\u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"leukemia-guide-tip\">需要注意：漏服化疗药物不可自行补服，请及时联系医生。\u003C/span>\n  \u003C/div>\n\n  \u003C!-- 02 剂型特点与服用技巧 -->\n  \u003Ch2 class=\"leukemia-guide-subtitle leukemia-guide-bg2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 剂型与服用技巧 💊\u003C/h2>\n  \u003Cdiv class=\"leukemia-guide-section\">\n    急性B细胞淋巴母白血病二期用药以注射剂和口服片剂为主，也包括输血制品等。不同剂型用法各有重点：\u003Cbr>\n    \u003Cstrong>正确做法：\u003C/strong>\n    \u003Cul class=\"leukemia-guide-list\">\n      \u003Cli>片剂不要掰碎、嚼服，除非说明书中特别允许，否则可能破坏控释或肠溶特性。\u003C/li>\n      \u003Cli>注射液应确保与原包装溶剂配伍，稀释后尽快使用，严禁私自储存稀释液以免细菌污染。\u003C/li>\n      \u003Cli>输注血液制品如血小板、红细胞悬液，需专用输血器械，避免与其他药液混用。\u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"leukemia-guide-tip\">特别提醒：输注类药品务必按规定专用通路，防止污染和混合反应。\u003C/span>\n  \u003C/div>\n\n  \u003C!-- 03 药物作用机制简述 -->\n  \u003Ch2 class=\"leukemia-guide-subtitle leukemia-guide-bg3\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 药品作用机制简单说 ⚗️\u003C/h2>\n  \u003Cdiv class=\"leukemia-guide-section\">\n    这里不细讲疾病，只讲主要药品机制：\u003Cbr>\n    \u003Cul class=\"leukemia-guide-list\">\n      \u003Cli>化疗药（如长春新碱、环磷酰胺）通过阻断白细胞增殖，抑制肿瘤细胞DNA合成，从而减少异常细胞。\u003C/li>\n      \u003Cli>靶向药物（如伊马替尼、利妥昔单抗）作用于特定细胞信号通路或表达的分子靶点，精准清除异常B细胞。\u003C/li>\n      \u003Cli>皮质激素（如泼尼松）通过调控免疫反应，提高化疗敏感性，有助于快速降低异常细胞。\u003C/li>\n      \u003Cli>支持用药（如重组人粒细胞刺激因子）促进正常白细胞恢复，提高机体抗感染能力。\u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"leukemia-guide-tip\">需要注意：作用机制决定了可能出现的特殊副作用，需密切监测。\u003C/span>\n  \u003C/div>\n\n  \u003C!-- 04 用药注意事项与禁忌症 -->\n  \u003Ch2 class=\"leukemia-guide-subtitle leukemia-guide-bg4\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 用药禁忌与特别注意事项 🚫\u003C/h2>\n  \u003Cdiv class=\"leukemia-guide-section\">\n    急性B细胞淋巴母白血病用药禁忌和高风险人群需严格把控——\n    \u003Cstrong>例如：\u003C/strong>\n    \u003Cul class=\"leukemia-guide-list\">\n      \u003Cli>对任何主要药品成分过敏者禁止使用相应药物。\u003C/li>\n      \u003Cli>肝、肾功能重度受损时，部分药品（如甲氨蝶呤）应减少剂量或停用。\u003C/li>\n      \u003Cli>孕妇及哺乳期妇女，在没有明确获益的情况下不建议使用化疗及大部分靶向药。\u003C/li>\n      \u003Cli>合并活动性严重感染、出血性疾病患者，应谨慎选择和调整药品类型。\u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"leukemia-guide-tip\">正确做法：用药前需全面评估个人过敏史及肝肾功能，不确定时请及时与医生沟通。\u003C/span>\n  \u003C/div>\n\n  \u003C!-- 05 药物相互作用要点整理 -->\n  \u003Ch2 class=\"leukemia-guide-subtitle leukemia-guide-bg5\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 常见药物相互作用 📋\u003C/h2>\n  \u003Cdiv class=\"leukemia-guide-section\">\n    治疗方案复杂时，药物配伍至关重要。\u003Cbr>\n    \u003Cul class=\"leukemia-guide-list\">\n      \u003Cli>部分抗真菌药（如伊曲康唑）可增强某些化疗药物的毒性，应适当监测药物浓度。\u003C/li>\n      \u003Cli>甲氨蝶呤不能与某些NSAIDs（如布洛芬）同时使用，否则会增加骨髓抑制和肾脏损害风险。\u003C/li>\n      \u003Cli>激素类药物遇到抗生素（如利福平）容易影响激素疗效和清除速度。\u003C/li>\n      \u003Cli>部分维生素和矿物质补充剂会降低化疗药物活性，如避开大量叶酸与甲氨蝶呤同时服用。\u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"leukemia-guide-tip\">正确做法：务必告知医生所有正在使用的药物，包括非处方药与保健品，严禁自行叠加用药。\u003C/span>\n  \u003C/div>\n\n  \u003C!-- 06 常见不良反应及处理办法 -->\n  \u003Ch2 class=\"leukemia-guide-subtitle leukemia-guide-bg6\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 常见不良反应及处理方法 🩹\u003C/h2>\n  \u003Cdiv class=\"leukemia-guide-section\">\n    白血病二期治疗涉及的药物副作用较多，部分不良反应较为典型——\n    \u003Cul class=\"leukemia-guide-list\">\n      \u003Cli>化疗药易致脱发、口腔溃疡、恶心呕吐、骨髓抑制，需定期复查血象并对症处理。\u003C/li>\n      \u003Cli>靶向药物偶见皮疹、注射部位反应和免疫相关副作用。\u003C/li>\n      \u003Cli>大量输注血制品偶可有发热、过敏等，需全程监测及时应对。\u003C/li>\n      \u003Cli>泼尼松可引起血糖升高、胃肠不适及失眠，应注意饮食调节并做好监测。\u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"leukemia-guide-tip\">\n      处理方案：一旦出现严重不适、皮肤出血、持续发热等不良反应，请第一时间联系医生，不要自行停药或减量。\n    \u003C/span>\n    \u003Cbr>\n    \u003Cdiv class=\"leukemia-guide-case\">\n      \u003Cstrong>临床案例：\u003C/strong> \n      \u003Cspan>有位女性患者在化疗期间出现轻微出血和发热反复，通过调整输注血小板并配合支持用药，有效缓解了副作用。\u003C/span>\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 07 储存条件及药品管理 -->\n  \u003Ch2 class=\"leukemia-guide-subtitle leukemia-guide-bg7\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 储存方式与有效期提醒 🗃️\u003C/h2>\n  \u003Cdiv class=\"leukemia-guide-section\">\n    药品储存合理，才能确保药效安全——\n    \u003Cul class=\"leukemia-guide-list\">\n      \u003Cli>绝大多数注射剂、输注液需要冷藏，2-8℃保存，避免反复冷冻。\u003C/li>\n      \u003Cli>口服片剂须避光、干燥处存放，远离儿童。\u003C/li>\n      \u003Cli>稀释后药品如未用完，应丢弃，切勿长时间放置或重复使用。\u003C/li>\n      \u003Cli>开封后如有异味、变色等异常，应停止服用并及时处理。\u003C/li> \n      \u003Cli>所有药品一旦过期不可再用，妥善丢弃，不得与生活垃圾混杂。\u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"leukemia-guide-tip\">正确做法：每次拿药时注意检查包装和有效期，发现异常立即更换并告知相关人员。\u003C/span>\n  \u003C/div>\n\n  \u003C!-- 08 特殊人群及剂量调整补充 -->\n  \u003Ch2 class=\"leukemia-guide-subtitle leukemia-guide-bg8\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 特殊人群用药与剂量调整 👵\u003C/h2>\n  \u003Cdiv class=\"leukemia-guide-section\">\n    药物剂量和选择应考虑个体特点：\u003Cbr>\n    \u003Cul class=\"leukemia-guide-list\">\n      \u003Cli>老人和儿童体重及代谢特点不同，需根据体表面积精准计算剂量，绝不凭经验加减。\u003C/li>\n      \u003Cli>肝肾功能减退者部分药品需要减量，常规剂量可能导致毒性增加。\u003C/li>\n      \u003Cli>妊娠、备孕及哺乳期妇女应严格避开化疗药及大多数免疫/靶向药（除非有特殊指征）。\u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"leukemia-guide-tip\">正确做法：遇到特殊情况改变用药方案前，务必由专业医师评估，不可随意调整。\u003C/span>\n    \u003Cbr>\n    \u003Cdiv class=\"leukemia-guide-case\">\n      \u003Cstrong>案例补充：\u003C/strong>\n      \u003Cspan>一位合并肝功能障碍的患者，医生调低了部分化疗药的剂量，明显降低了药物毒性反应。\u003C/span>\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 09 药品使用与生活细节 -->\n  \u003Ch2 class=\"leukemia-guide-subtitle leukemia-guide-bg9\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09 用药相关的生活建议 🌱\u003C/h2>\n  \u003Cdiv class=\"leukemia-guide-section\">\n    急性B细胞淋巴母白血病药物治疗期间，生活上的小细节同样重要：\u003Cbr>\n    \u003Cul class=\"leukemia-guide-list\">\n      \u003Cli>用药期间保持良好个人卫生，预防感染十分关键。\u003C/li>\n      \u003Cli>减少暴露于人群密集场所，尤其骨髓抑制期。\u003C/li>\n      \u003Cli>调整饮食结构，适当补充蛋白质及维生素，配合药物恢复身体机能。\u003C/li>\n      \u003Cli>每次服药可用一本小本记录，避免遗漏和混淆。\u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"leukemia-guide-tip\">建议：家属协助做好全程用药监督，发现任何异常尽早反馈。\u003C/span>\n  \u003C/div>\n\n  \u003C!-- 10 漏服与过量如何处理 -->\n  \u003Ch2 class=\"leukemia-guide-subtitle leukemia-guide-bg10\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">10 遇到漏服/过量时怎么办？⛑️\u003C/h2>\n  \u003Cdiv class=\"leukemia-guide-section\">\n    治疗中偶有漏服和过量风险——\u003Cbr>\n    \u003Cul class=\"leukemia-guide-list\">\n      \u003Cli>如忘记及时服用一个剂量，回想起后如时间刚过可立即补服，若接近下一剂量，略过本次，不要双倍补救。\u003C/li>\n      \u003Cli>如不慎服用过量，或出现严重不良反应需立刻前往医院，请勿拖延。\u003C/li>\n      \u003Cli>千万不要自行停药、换药，防止突发恶性用药反应。\u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"leukemia-guide-tip\">正确做法：随身携带主要药品清单，关键用药可制作紧急通知卡给家属和护理人员。\u003C/span>\n  \u003C/div>\n\n  \u003C!-- 11 常用药品科普信息一览 -->\n  \u003Ch2 class=\"leukemia-guide-subtitle leukemia-guide-bg11\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">11 急性B细胞淋巴母白血病二期常用药品要点参考汇总 📖\u003C/h2>\n  \u003Cdiv class=\"leukemia-guide-section\">\n    \u003Ctable class=\"leukemia-guide-table\" style=\"width: 100%; margin: 1.5em 0px; border-collapse: collapse;\">\n      \u003Cthead>\n        \u003Ctr>\n          \u003Cth style=\"padding: 12px; border: 1px solid rgb(234, 236, 239); background-color: rgb(248, 249, 250);\">药品名称\u003C/th>\n          \u003Cth style=\"padding: 12px; border: 1px solid rgb(234, 236, 239); background-color: rgb(248, 249, 250);\">剂型\u003C/th>\n          \u003Cth style=\"padding: 12px; border: 1px solid rgb(234, 236, 239); background-color: rgb(248, 249, 250);\">关键用法\u003C/th>\n          \u003Cth style=\"padding: 12px; border: 1px solid rgb(234, 236, 239); background-color: rgb(248, 249, 250);\">不良反应\u003C/th>\n          \u003Cth style=\"padding: 12px; border: 1px solid rgb(234, 236, 239); background-color: rgb(248, 249, 250);\">特殊提示\u003C/th>\n        \u003C/tr>\n      \u003C/thead>\n      \u003Ctbody>\n        \u003Ctr>\n          \u003Ctd style=\"padding: 12px; border: 1px solid rgb(234, 236, 239);\">甲氨蝶呤\u003C/td>\n          \u003Ctd style=\"padding: 12px; border: 1px solid rgb(234, 236, 239);\">注射/片剂\u003C/td>\n          \u003Ctd style=\"padding: 12px; border: 1px solid rgb(234, 236, 239);\">按体表面积计算，一周1-2次，需监测肝肾功能\u003C/td>\n          \u003Ctd style=\"padding: 12px; border: 1px solid rgb(234, 236, 239);\">骨髓抑制、口腔炎\u003C/td>\n          \u003Ctd style=\"padding: 12px; border: 1px solid rgb(234, 236, 239);\">不可与大量叶酸同服\u003C/td>\n        \u003C/tr>\n        \u003Ctr>\n          \u003Ctd style=\"padding: 12px; border: 1px solid rgb(234, 236, 239);\">长春新碱\u003C/td>\n          \u003Ctd style=\"padding: 12px; border: 1px solid rgb(234, 236, 239);\">注射\u003C/td>\n          \u003Ctd style=\"padding: 12px; border: 1px solid rgb(234, 236, 239);\">小剂量分次注射，节律注射，避免外渗\u003C/td>\n          \u003Ctd style=\"padding: 12px; border: 1px solid rgb(234, 236, 239);\">外周神经病变\u003C/td>\n          \u003Ctd style=\"padding: 12px; border: 1px solid rgb(234, 236, 239);\">溶液避免直接接触皮肤\u003C/td>\n        \u003C/tr>\n        \u003Ctr>\n          \u003Ctd style=\"padding: 12px; border: 1px solid rgb(234, 236, 239);\">泼尼松\u003C/td>\n          \u003Ctd style=\"padding: 12px; border: 1px solid rgb(234, 236, 239);\">口服片\u003C/td>\n          \u003Ctd style=\"padding: 12px; border: 1px solid rgb(234, 236, 239);\">按体重/面积每天1-2次，逐渐减量停药\u003C/td>\n          \u003Ctd style=\"padding: 12px; border: 1px solid rgb(234, 236, 239);\">高血糖、感染倾向\u003C/td>\n          \u003Ctd style=\"padding: 12px; border: 1px solid rgb(234, 236, 239);\">配合血糖监测\u003C/td>\n        \u003C/tr>\n        \u003Ctr>\n          \u003Ctd style=\"padding: 12px; border: 1px solid rgb(234, 236, 239);\">伊马替尼\u003C/td>\n          \u003Ctd style=\"padding: 12px; border: 1px solid rgb(234, 236, 239);\">口服片\u003C/td>\n          \u003Ctd style=\"padding: 12px; border: 1px solid rgb(234, 236, 239);\">餐后用温水吞服，整片咽下\u003C/td>\n          \u003Ctd style=\"padding: 12px; border: 1px solid rgb(234, 236, 239);\">水肿、皮疹、胃肠反应\u003C/td>\n          \u003Ctd style=\"padding: 12px; border: 1px solid rgb(234, 236, 239);\">避免与葡萄柚同用\u003C/td>\n        \u003C/tr>\n        \u003Ctr>\n          \u003Ctd style=\"padding: 12px; border: 1px solid rgb(234, 236, 239);\">环磷酰胺\u003C/td>\n          \u003Ctd style=\"padding: 12px; border: 1px solid rgb(234, 236, 239);\">注射/片剂\u003C/td>\n          \u003Ctd style=\"padding: 12px; border: 1px solid rgb(234, 236, 239);\">大剂量需补液和利尿以防出血性膀胱炎\u003C/td>\n          \u003Ctd style=\"padding: 12px; border: 1px solid rgb(234, 236, 239);\">脱发、恶心、膀胱炎\u003C/td>\n          \u003Ctd style=\"padding: 12px; border: 1px solid rgb(234, 236, 239);\">同时配利尿剂\u003C/td>\n        \u003C/tr>\n        \u003Ctr>\n          \u003Ctd style=\"padding: 12px; border: 1px solid rgb(234, 236, 239);\">利妥昔单抗\u003C/td>\n          \u003Ctd style=\"padding: 12px; border: 1px solid rgb(234, 236, 239);\">注射液\u003C/td>\n          \u003Ctd style=\"padding: 12px; border: 1px solid rgb(234, 236, 239);\">缓慢滴注首剂，监测过敏\u003C/td>\n          \u003Ctd style=\"padding: 12px; border: 1px solid rgb(234, 236, 239);\">发热、过敏反应\u003C/td>\n          \u003Ctd style=\"padding: 12px; border: 1px solid rgb(234, 236, 239);\">有心脏病史需警惕\u003C/td>\n        \u003C/tr>\n        \u003Ctr>\n          \u003Ctd style=\"padding: 12px; border: 1px solid rgb(234, 236, 239);\">重组人粒细胞刺激因子\u003C/td>\n          \u003Ctd style=\"padding: 12px; border: 1px solid rgb(234, 236, 239);\">注射液\u003C/td>\n          \u003Ctd style=\"padding: 12px; border: 1px solid rgb(234, 236, 239);\">每天1次皮下注射，常用于化疗期间\u003C/td>\n          \u003Ctd style=\"padding: 12px; border: 1px solid rgb(234, 236, 239);\">注射部位疼痛\u003C/td>\n          \u003Ctd style=\"padding: 12px; border: 1px solid rgb(234, 236, 239);\">不与化疗药同日使用\u003C/td>\n        \u003C/tr>\n      \u003C/tbody>\n    \u003C/table>\n  \u003C/div>\n\n  \u003C!-- 12 总结与安全提醒 -->\n  \u003Ch2 class=\"leukemia-guide-subtitle leukemia-guide-bg12\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">12 结语与重点回顾 📝\u003C/h2>\n  \u003Cdiv class=\"leukemia-guide-section leukemia-guide-conclusion\">\n    急性B细胞淋巴母细胞白血病二期所涉及的药品，每一步都需要严格按规范操作，尤其是剂型选择、服用时间、剂量调整以及不良反应的处理。用药记录、药品储存、特殊人群剂量的合理调整，也是安全高效治疗的关键。\u003Cbr>\n    \u003Cstrong>再次强调：\u003C/strong>\n    \u003Cul class=\"leukemia-guide-list\">\n      \u003Cli>任何和用药相关的异常，一定要及时和专业医生核实，切勿疏忽。\u003C/li>\n      \u003Cli>记录好全部用药信息，是守护家庭用药安全的第一步。\u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"leukemia-guide-tip\">养成规范、清晰的用药习惯，对治疗成效和康复过程至关重要。\u003C/span>\n  \u003C/div>\n\n  \u003C!-- 参考文献 -->\n  \u003Cdiv class=\"leukemia-guide-references\">\n    \u003Ch3 class=\"leukemia-guide-ref-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">📚 参考文献\u003C/h3>\n    \u003Cul class=\"leukemia-guide-ref-list\">\n      \u003Cli>\n        DeAngelo, D. J., Yu, D., Johnson, J. L., et al. (2021). Long-term Outcomes with Imatinib-Based Therapy in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: The ECOG E2993 Study. \u003Cem>Blood\u003C/em>, 137(13), 1724–1735. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/33561004/\" target=\"_blank\">PubMed\u003C/a>\n      \u003C/li>\n      \u003Cli>\n        Vardiman, J. W., Thiele, J., Arber, D. A., et al. (2009). The 2008 Revision of the World Health Organization (WHO) Classification of Myeloid Neoplasms and Acute Leukemia: Rationale and Important Changes. \u003Cem>Blood\u003C/em>, 114(5), 937–951. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/19357394/\" target=\"_blank\">PubMed\u003C/a>\n      \u003C/li>\n      \u003Cli>\n        Kantarjian, H., Thomas, D., O'Brien, S., et al. (2004). Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia. \u003Cem>Cancer\u003C/em>, 101(12), 2788–2801. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/15593029/\" target=\"_blank\">PubMed\u003C/a>\n      \u003C/li>\n      \u003Cli>\n        Pui, C.H., Mullighan, C.G. (2021). Acute lymphoblastic leukemia. \u003Cem>The New England Journal of Medicine\u003C/em>, 386(5), 461-473. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/35120646/\" target=\"_blank\">PubMed\u003C/a>\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/div>\n\u003Cstyle>\n.leukemia-guide-material {\n  background-color: #fbfbff;\n  color: #293143;\n  max-width: 860px;\n  margin: 40px auto;\n  border-radius: 10px;\n  font-family: \"Segoe UI\", Arial, sans-serif;\n  box-shadow: 0 6px 32px rgba(75, 83, 99, 0.08);\n  padding: 30px 34px 44px 34px;\n  font-size: 18px;\n  line-height: 1.85;\n}\n.leukemia-guide-title {\n  text-align: center;\n  font-size: 2.1em;\n  letter-spacing: 2px;\n  color: #216dc6;\n  margin-bottom: 24px;\n  font-weight: bold;\n}\n\n.leukemia-guide-bg-section {\n  background-color: #e9f1fc;\n  border-radius: 7px;\n  padding: 18px 28px;\n  margin-bottom: 22px;\n}\n\n.leukemia-guide-subtitle {\n  font-size: 1.25em;\n  color: #1658a6;\n  font-weight: 600;\n  margin-top: 44px;\n  margin-bottom: 13px;\n  padding: 12px 24px;\n  border-radius: 7px;\n  box-shadow: 0 1px 10px rgba(85, 170, 255, 0.05);\n  background-repeat: no-repeat;\n  background-size: cover;\n}\n\n.leukemia-guide-bg1{background:linear-gradient(90deg, #e3f0fc 65%, #cddeff 100%);}\n.leukemia-guide-bg2{background:linear-gradient(90deg, #f0eafd 65%, #e9d7f7 100%);}\n.leukemia-guide-bg3{background:linear-gradient(90deg, #eafdee 65%, #d7f7ec 100%);}\n.leukemia-guide-bg4{background:linear-gradient(90deg, #fdf6ea 65%, #f7e7d7 100%);}\n.leukemia-guide-bg5{background:linear-gradient(90deg, #f2eafc 65%, #e4d7f7 100%);}\n.leukemia-guide-bg6{background:linear-gradient(90deg, #eafcfa 65%, #d7f7f5 100%);}\n.leukemia-guide-bg7{background:linear-gradient(90deg, #f7faea 65%, #f4ffd7 100%);}\n.leukemia-guide-bg8{background:linear-gradient(90deg, #fceafc 65%, #f7d7f4 100%);}\n.leukemia-guide-bg9{background:linear-gradient(90deg, #eaf2fd 65%, #d7e8f7 100%);}\n.leukemia-guide-bg10{background:linear-gradient(90deg, #eafdeb 65%, #d7fad7 100%);}\n.leukemia-guide-bg11{background:linear-gradient(90deg, #fdefea 65%, #ffe9d7 100%);}\n.leukemia-guide-bg12{background:linear-gradient(90deg, #eafcfe 0%, #e9f7fa 100%);}\n\n.leukemia-guide-section {\n  padding: 18px 22px 16px 22px;\n  margin-bottom: 24px;\n  background: #ffffff;\n  border-radius: 6px;\n  border: 1px solid #e0e5ed;\n  position: relative;\n}\n\n.leukemia-guide-list {\n  margin: 10px 0 10px 36px; \n  padding: 0;\n  list-style: disc;\n  line-height: 2.05;\n}\n\n.leukemia-guide-table {\n  width: 100%;\n  margin-top: 12px;\n  border-collapse: collapse;\n  font-size: 1em;\n}\n.leukemia-guide-table th, .leukemia-guide-table td {\n  border: 1px solid #dbeafe;\n  padding: 9px 5px;\n  text-align: left;\n  background-color: #fafbfd;\n}\n.leukemia-guide-table th {\n  background-color: #e9f4fe;\n  color: #145593;\n  font-size: 1.06em;\n  font-weight: 500;\n}\n\n.leukemia-guide-tip {\n  display: block;\n  background-color: #e1ecfa;\n  color: #125196;\n  border-left: 4px solid #6db7ee;\n  padding: 8px 15px;\n  margin: 12px 0 5px 0;\n  font-size: 0.96em;\n  border-radius: 3px;\n}\n\n.leukemia-guide-case {\n  margin: 13px 0 0 0;\n  padding: 11px 18px;\n  background: #f9f3ea;\n  border-left: 4px solid #f3cd84;\n  border-radius: 3px;\n  font-size: 0.97em;\n}\n\n.leukemia-guide-references {\n  margin-top: 48px;\n  background: #f6faff;\n  padding: 15px 20px 20px 30px;\n  border-radius: 6px;\n  border: 1px solid #dbeafe;\n}\n.leukemia-guide-ref-title {\n  font-size: 1.11em;\n  color: #175589;\n  margin-bottom: 10px;\n  margin-top: 0;\n}\n.leukemia-guide-ref-list {\n  list-style: none;\n  margin: 7px 0 0 0;\n  padding: 0;\n  font-size: 0.99em;\n}\n.leukemia-guide-ref-list li {\n  margin-bottom: 5px;\n  line-height: 1.8;\n}\n.leukemia-guide-ref-list em{\n  font-style:italic;\n  color:#145593;\n}\n.leukemia-guide-conclusion{\n  background:#f4f9fd !important;\n  border-color:#e7eef8 !important;\n}\n@media (max-width:660px) {\n  .leukemia-guide-material {padding:13px 2px 24px 2px;font-size:16px;}\n  .leukemia-guide-title{font-size:1.36em;padding:0 4px;}\n  .leukemia-guide-section {padding: 11px 5px;}\n}\n\u003C/style>\n\n","\u003Cdiv class=\"leukemia-guide-material\">\n  \u003Ch1 id=\"material_title\" class=\"leukemia-guide-title\" style=\"",526,"2025-08-29 09:26:35","急性B细胞淋巴母白血病, 安全用药, 化疗药物, 靶向药物, 药物不良反应, 用药禁忌, 患者指导, 医疗建议","了解急性B细胞淋巴母白血病二期的安全用药要点。这份实用指南将帮助患者及其家属有效应对化疗药物和靶向药物的使用，确保治疗效果与安全性。","2025-09-07 11:30:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]